世界の生体材料市場

出版:Inkwood Research(インクウッドリサーチ) 出版年月:2021年11月

GLOBAL BIOMATERIALS MARKET FORECAST 2021-2028
世界の生体材料市場の予測2021-2028

ページ数 312
価格
シングルユーザライセンス USD 2,500
マルチユーザライセンス USD 3,000
エンタープライズライセンス USD 4,500
種別 英文調査報告書

このレポートへお問合せ  レポート目次

関連市場調査レポート

Inkwood Researchでは下記地域/国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。

    • ドイツの生体材料市場の予測2021-2026
      GERMANY BIOMATERIALS MARKET FORECAST 2021-2026
    • アメリカ合衆国の生体材料市場の予測2021-2026
      UNITED STATES BIOMATERIALS MARKET FORECAST 2021-2026


KEY FINDINGS
The global biomaterials market is projected to develop with a CAGR of 13.45% over the projected years of 2021 to 2028. The market growth is attributable to key factors such as the use of biomaterials in plastic surgeries as well as bone fixation, inventions in the field of biomaterials, government support for research and development initiatives, applications of biomaterials in wound healing therapies, and the high incidence of cardiovascular diseases and geriatric population.
MARKET INSIGHTS
Biomaterials are characterized as substances engineered to become biocompatible for their interaction with biological systems. Biomaterials can be categorized as synthetic and natural. Synthetic materials comprise metals, ceramics, and polymers, whereas natural biomaterials are derived from natural sources, including animal tissues, or are engineered in laboratories.
Biomaterials are increasingly found in bioimplant devices, assisting in the treatment of bone fixation and plastic surgeries globally. These materials facilitate fabrication and flexibility and are biocompatible. Moreover, their range of mechanical, chemical, electrical, and thermal behaviors widen when integrated with different materials as composites. As per the Australian National Joint Replacement Registry, the total number of joint replacement procedures performed in Australia was 1,492,892 at the end of 2018. Moreover, in the same year, knee replacements rose by 1.2%, with the revision burden equating to 8.7%.
REGIONAL INSIGHTS
The global biomaterials market growth evaluation constitutes the assessment of Asia-Pacific, North America, Europe, and Rest of World. The Asia-Pacific is anticipated to grow with the highest CAGR over the forecasted years. The regional market’s growth is primarily credited to the steady population growth and the increasing urbanization. Moreover, effective government policies combined with financial support in research and development across emerging economies like India and South Korea play a vital role, as well.
COMPETITIVE INSIGHTS
The intensity of industrial rivalry entails the extent to which manufacturers within the global biomaterials market can increase the pressure to gain a competitive advantage across international and regional markets. As a result, the competition in the global biomaterials market is expected to remain high during the forecast period.
The top firms operating in the market are Royal DSM, Zimmer Biomet, BASF SE, Evonik Industries, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. USAGE OF BIOMATERIALS IN THE TREATMENT OF BONE FIXATION AND PLASTIC SURGERIES
3.1.2. PREVALENCE OF GERIATRIC POPULATION AND CARDIOVASCULAR DISEASES
3.1.3. INVENTIONS IN THE FIELD OF BIOMATERIALS
3.1.4. GOVERNMENT SUPPORT FOR RESEARCH AND DEVELOPMENT INITIATIVES
3.1.5. APPLICATIONS OF BIOMATERIALS IN PLASTIC SURGERY AND WOUND HEALING THERAPIES
3.2. KEY RESTRAINTS
3.2.1. BIOCOMPATIBILITY ISSUES ASSOCIATED WITH BIOMATERIALS
3.2.2. STRINGENT REGULATIONS
3.2.3. HIGH PRICE OF IMPLANTABLE BIOMATERIALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOMATERIALS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. SUPPLY CHAIN ANALYSIS
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. METAL-BASED BIOMATERIALS
5.1.1. STAINLESS STEEL
5.1.2. TITANIUM AND TITANIUM ALLOYS
5.1.3. CO-CR ALLOYS
5.1.4. MAGNESIUM
5.1.5. GOLD
5.1.6. SILVER
5.1.7. NITINOL
5.1.8. OTHER METAL-BASED BIOMATERIALS
5.2. POLYMER-BASED BIOMATERIALS
5.2.1. PMMA
5.2.2. POLYETHYLENE TEREPHTHALATE
5.2.3. POLYESTER
5.2.4. POLYVINYLCHLORIDE
5.2.5. SILICONE RUBBER
5.2.6. NYLON
5.2.7. POLYETHERETHERKETONE
5.2.8. OTHER POLYMER-BASED BIOMATERIALS
5.3. CERAMIC-BASED BIOMATERIALS
5.3.1. CALCIUM PHOSPHATE
5.3.2. ALUMINUM OXIDE
5.3.3. CALCIUM SULFATE
5.3.4. ZIRCONIA
5.3.5. CARBON
5.3.6. GLASS
5.4. NATURAL-BASED BIOMATERIALS
5.4.1. HYALURONIC ACID
5.4.2. FIBRIN
5.4.3. COLLAGEN & GELATIN
5.4.4. CELLULOSE
5.4.5. CHITIN
5.4.6. ALGINATES
5.4.7. SILK
5.5. INORGANIC GLASS-BASED BIOMATERIALS
5.6. RADIOPAQUE BIOMATERIALS
5.7. REGENERATIVE BIOMATERIALS
5.8. HYBRID BIOMATERIALS COMBINATIONS
6. MARKET BY APPLICATION
6.1. CARDIOVASCULAR
6.1.1. CATHETERS
6.1.2. STENTS
6.1.3. HEART VALVES
6.1.4. GUIDEWIRES
6.1.5. SENSORS
6.1.6. PACEMAKER
6.1.7. IMPLANTABLE CARDIAC DEFIBRILLATORS
6.1.8. VASCULAR GRAFTS
6.2. ORTHOPEDIC
6.2.1. JOINT REPLACEMENT
6.2.2. VISCOSUPPLEMENTATION
6.2.3. BIORESORBABLE TISSUE FIXATION
6.2.4. SPINE
6.2.5. FRACTURE FIXATION
6.2.6. ORTHOBIOLOGY
6.3. OPHTHALMOLOGY
6.3.1. CONTACT LENSES
6.3.2. INTRAOCULAR LENSES
6.3.3. FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
6.3.4. SYNTHETIC CORNEAS
6.3.5. OTHER OPHTHALMOLOGY APPLICATIONS
6.4. DENTAL
6.4.1. DENTAL BONE GRAFTS AND SUBSTITUTES
6.4.2. DENTAL MEMBRANES
6.5. WOUND HEALING
6.5.1. WOUND CLOSURE DEVICES
6.5.2. SUTURES
6.5.3. STAPLES
6.5.4. SURGICAL HAEMOSTATS
6.5.5. INTERNAL TISSUE SEALANTS
6.5.6. ADHESION BARRIERS
6.5.7. HERNIA MESHES
6.6. PLASTIC SURGERY
6.6.1. SOFT-TISSUE FILLERS
6.6.2. CRANIOFACIAL SURGERY
6.7. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
6.7.1. SHUNTING SYSTEMS
6.7.2. CORTICAL NEURAL PROSTHETICS (CNP)
6.7.3. HYDROGEL SCAFFOLDS
6.7.4. NEURAL STEM CELL ENCAPSULATION
6.8. TISSUE ENGINEERING
6.8.1. SCAFFOLDS FOR REGENERATIVE MEDICINE
6.8.2. NANOMATERIAL FOR BIOSENSING
6.8.3. TAILORING OF INORGANIC NANOPARTICLES
6.9. OTHER APPLICATIONS
6.9.1. DRUG DELIVERY SYSTEMS
6.9.2. GASTROINTESTINAL APPLICATIONS
6.9.3. BARIATRIC SURGERY
6.9.4. URINARY APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. KEY GROWTH ENABLERS
7.2.3. KEY CHALLENGES
7.2.4. KEY PLAYERS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. POLAND
7.2.5.7. BELGIUM
7.2.5.8. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. KEY GROWTH ENABLERS
7.3.3. KEY CHALLENGES
7.3.4. KEY PLAYERS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA & NEW ZEALAND
7.3.5.5. SOUTH KOREA
7.3.5.6. THAILAND
7.3.5.7. INDONESIA
7.3.5.8. VIETNAM
7.3.5.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. KEY GROWTH ENABLERS
7.4.3. KEY CHALLENGES
7.4.4. KEY PLAYERS
7.4.5. REGIONAL ANALYSIS
7.4.5.1. LATIN AMERICA
7.4.5.2. MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BASF
8.2.2. BBS-BIOACTIVE BONE SUBSTITUTES
8.2.3. BIORETEC LTD
8.2.4. CARPENTER TECHNOLOGY CORPORATION
8.2.5. CELANESE CORPORATION
8.2.6. COLLAGEN SOLUTIONS PLC
8.2.7. CORBION NV
8.2.8. COVESTRO AG
8.2.9. DENTSPLY SIRONA
8.2.10. EVONIK INDUSTRIES
8.2.11. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
8.2.12. NOBLE BIOMATERIALS INC
8.2.13. ROYAL DSM
8.2.14. VICTREX PLC
8.2.15. WRIGHT MEDICAL GROUP NV
8.2.16. ZIMMER BIOMET HOLDINGS INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – BIOMATERIALS
TABLE 2: GERIATRIC POPULATION ACROSS DIFFERENT REGIONS (60 YEARS & ABOVE)
TABLE 3: GLOBAL BIOMATERIALS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: GLOBAL BIOMATERIALS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL METAL-BASED BIOMATERIALS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: GLOBAL METAL-BASED BIOMATERIALS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL POLYMER-BASED BIOMATERIALS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: GLOBAL POLYMER-BASED BIOMATERIALS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL CERAMIC-BASED BIOMATERIALS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 10: GLOBAL CERAMIC-BASED BIOMATERIALS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL NATURAL-BASED BIOMATERIALS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 12: GLOBAL NATURAL-BASED BIOMATERIALS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL BIOMATERIALS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 14: GLOBAL BIOMATERIALS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL CARDIOVASCULAR MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: GLOBAL CARDIOVASCULAR MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: GLOBAL ORTHOPEDIC MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: GLOBAL ORTHOPEDIC MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 19: GLOBAL OPHTHALMOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: GLOBAL OPHTHALMOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 21: GLOBAL DENTAL MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 22: GLOBAL DENTAL MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 23: GLOBAL WOUND HEALING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 24: GLOBAL WOUND HEALING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 25: GLOBAL PLASTIC SURGERY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL PLASTIC SURGERY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: GLOBAL NEUROLOGICAL/CENTRAL NERVOUS SYSTEM MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: GLOBAL NEUROLOGICAL/CENTRAL NERVOUS SYSTEM MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: GLOBAL TISSUE ENGINEERING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 30: GLOBAL TISSUE ENGINEERING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 31: GLOBAL OTHER APPLICATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 32: GLOBAL OTHER APPLICATIONS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 33: GLOBAL BIOMATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: GLOBAL BIOMATERIALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: NORTH AMERICA BIOMATERIALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 36: NORTH AMERICA BIOMATERIALS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 37: LEADING PLAYERS OPERATING IN NORTH AMERICA BIOMATERIALS MARKET
TABLE 38: EUROPE BIOMATERIALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: EUROPE BIOMATERIALS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: LEADING PLAYERS OPERATING IN EUROPE BIOMATERIALS MARKET
TABLE 41: ASIA-PACIFIC BIOMATERIALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 42: ASIA-PACIFIC BIOMATERIALS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 43: LEADING PLAYERS OPERATING IN ASIA-PACIFIC BIOMATERIALS MARKET
TABLE 44: REST OF WORLD BIOMATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: REST OF WORLD BIOMATERIALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: LEADING PLAYERS OPERATING IN REST OF WORLD BIOMATERIALS MARKET
TABLE 47: LIST OF MERGERS & ACQUISITIONS
TABLE 48: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 49: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 50: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES
FIGURE 1: PLASTIC SURGERY PROCEDURES PERFORMED IN VARIOUS COUNTRIES IN 2019
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: SUPPLY CHAIN ANALYSIS
FIGURE 5: OPPORTUNITY MATRIX
FIGURE 6: VENDOR LANDSCAPE
FIGURE 7: GLOBAL BIOMATERIALS MARKET, BY PRODUCT, IN 2020
FIGURE 8: GLOBAL BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL BIOMATERIALS MARKET, BY STAINLESS STEEL, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL BIOMATERIALS MARKET, BY TITANIUM AND TITANIUM ALLOYS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL BIOMATERIALS MARKET, BY CO-CR ALLOYS, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL BIOMATERIALS MARKET, BY MAGNESIUM, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL BIOMATERIALS MARKET, BY GOLD, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL BIOMATERIALS MARKET, BY SILVER, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL BIOMATERIALS MARKET, BY NITINOL, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL BIOMATERIALS MARKET, BY OTHER METAL-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL BIOMATERIALS MARKET, BY PMMA, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL BIOMATERIALS MARKET, BY POLYETHYLENE TEREPHTHALATE, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL BIOMATERIALS MARKET, BY POLYESTER, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL BIOMATERIALS MARKET, BY POLYVINYLCHLORIDE, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL BIOMATERIALS MARKET, BY SILICONE RUBBER, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL BIOMATERIALS MARKET, BY NYLON, 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL BIOMATERIALS MARKET, BY POLYETHERETHERKETONE, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL BIOMATERIALS MARKET, BY OTHER POLYMER-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 27: GLOBAL BIOMATERIALS MARKET, BY CALCIUM PHOSPHATE, 2021-2028 (IN $ MILLION)
FIGURE 28: GLOBAL BIOMATERIALS MARKET, BY ALUMINUM OXIDE, 2021-2028 (IN $ MILLION)
FIGURE 29: GLOBAL BIOMATERIALS MARKET, BY CALCIUM SULFATE, 2021-2028 (IN $ MILLION)
FIGURE 30: GLOBAL BIOMATERIALS MARKET, BY ZIRCONIA, 2021-2028 (IN $ MILLION)
FIGURE 31: GLOBAL BIOMATERIALS MARKET, BY CARBON, 2021-2028 (IN $ MILLION)
FIGURE 32: GLOBAL BIOMATERIALS MARKET, BY GLASS, 2021-2028 (IN $ MILLION)
FIGURE 33: GLOBAL BIOMATERIALS MARKET, BY NATURAL-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 34: GLOBAL BIOMATERIALS MARKET, BY HYALURONIC ACID, 2021-2028 (IN $ MILLION)
FIGURE 35: GLOBAL BIOMATERIALS MARKET, BY FIBRIN, 2021-2028 (IN $ MILLION)
FIGURE 36: GLOBAL BIOMATERIALS MARKET, BY COLLAGEN & GELATIN, 2021-2028 (IN $ MILLION)
FIGURE 37: GLOBAL BIOMATERIALS MARKET, BY CELLULOSE, 2021-2028 (IN $ MILLION)
FIGURE 38: GLOBAL BIOMATERIALS MARKET, BY CHITIN, 2021-2028 (IN $ MILLION)
FIGURE 39: GLOBAL BIOMATERIALS MARKET, BY ALGINATES, 2021-2028 (IN $ MILLION)
FIGURE 40: GLOBAL BIOMATERIALS MARKET, BY SILK, 2021-2028 (IN $ MILLION)
FIGURE 41: GLOBAL BIOMATERIALS MARKET, BY INORGANIC GLASS-BASED BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 42: GLOBAL BIOMATERIALS MARKET, BY RADIOPAQUE BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 43: GLOBAL BIOMATERIALS MARKET, BY REGENERATIVE BIOMATERIALS, 2021-2028 (IN $ MILLION)
FIGURE 44: GLOBAL BIOMATERIALS MARKET, BY HYBRID BIOMATERIALS COMBINATIONS, 2021-2028 (IN $ MILLION)
FIGURE 45: GLOBAL BIOMATERIALS MARKET, BY APPLICATION, IN 2020
FIGURE 46: GLOBAL BIOMATERIALS MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 47: GLOBAL CARDIOVASCULAR MARKET, BY CATHETERS, 2021-2028 (IN $ MILLION)
FIGURE 48: GLOBAL CARDIOVASCULAR MARKET, BY STENTS, 2021-2028 (IN $ MILLION)
FIGURE 49: GLOBAL CARDIOVASCULAR MARKET, BY HEART VALVES, 2021-2028 (IN $ MILLION)
FIGURE 50: GLOBAL CARDIOVASCULAR MARKET, BY GUIDEWIRES, 2021-2028 (IN $ MILLION)
FIGURE 51: GLOBAL CARDIOVASCULAR MARKET, BY SENSORS, 2021-2028 (IN $ MILLION)
FIGURE 52: GLOBAL CARDIOVASCULAR MARKET, BY PACEMAKER, 2021-2028 (IN $ MILLION)
FIGURE 53: GLOBAL CARDIOVASCULAR MARKET, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, 2021-2028 (IN $ MILLION)
FIGURE 54: GLOBAL CARDIOVASCULAR MARKET, BY VASCULAR GRAFTS, 2021-2028 (IN $ MILLION)
FIGURE 55: GLOBAL BIOMATERIALS MARKET, BY ORTHOPEDIC, 2021-2028 (IN $ MILLION)
FIGURE 56: GLOBAL ORTHOPEDIC MARKET, BY JOINT REPLACEMENT, 2021-2028 (IN $ MILLION)
FIGURE 57: GLOBAL ORTHOPEDIC MARKET, BY VISCOSUPPLEMENTATION, 2021-2028 (IN $ MILLION)
FIGURE 58: GLOBAL ORTHOPEDIC MARKET, BY BIORESORBABLE TISSUE FIXATION, 2021-2028 (IN $ MILLION)
FIGURE 59: GLOBAL ORTHOPEDIC MARKET, BY SPINE, 2021-2028 (IN $ MILLION)
FIGURE 60: GLOBAL ORTHOPEDIC MARKET, BY FRACTURE FIXATION, 2021-2028 (IN $ MILLION)
FIGURE 61: GLOBAL ORTHOPEDIC MARKET, BY ORTHOBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 62: GLOBAL BIOMATERIALS MARKET, BY OPHTHALMOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 63: GLOBAL OPHTHALMOLOGY MARKET, BY CONTACT LENSES, 2021-2028 (IN $ MILLION)
FIGURE 64: GLOBAL OPHTHALMOLOGY MARKET, BY INTRAOCULAR LENSES, 2021-2028 (IN $ MILLION)
FIGURE 65: GLOBAL OPHTHALMOLOGY MARKET, BY FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, 2021-2028 (IN $ MILLION)
FIGURE 66: GLOBAL OPHTHALMOLOGY MARKET, BY SYNTHETIC CORNEAS, 2021-2028 (IN $ MILLION)
FIGURE 67: GLOBAL OPHTHALMOLOGY MARKET, BY OTHER OPHTHALMOLOGY APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 68: GLOBAL BIOMATERIALS MARKET, BY DENTAL, 2021-2028 (IN $ MILLION)
FIGURE 69: GLOBAL DENTAL MARKET, BY DENTAL BONE GRAFTS AND SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 70: GLOBAL DENTAL MARKET, BY DENTAL MEMBRANES, 2021-2028 (IN $ MILLION)
FIGURE 71: GLOBAL BIOMATERIALS MARKET, BY WOUND HEALING, 2021-2028 (IN $ MILLION)
FIGURE 72: GLOBAL WOUND HEALING MARKET, BY WOUND CLOSURE DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 73: GLOBAL WOUND HEALING MARKET, BY SUTURES, 2021-2028 (IN $ MILLION)
FIGURE 74: GLOBAL WOUND HEALING MARKET, BY STAPLES, 2021-2028 (IN $ MILLION)
FIGURE 75: GLOBAL WOUND HEALING MARKET, BY SURGICAL HAEMOSTATS, 2021-2028 (IN $ MILLION)
FIGURE 76: GLOBAL WOUND HEALING MARKET, BY INTERNAL TISSUE SEALANTS, 2021-2028 (IN $ MILLION)
FIGURE 77: GLOBAL WOUND HEALING MARKET, BY ADHESION BARRIERS, 2021-2028 (IN $ MILLION)
FIGURE 78: GLOBAL WOUND HEALING MARKET, BY HERNIA MESHES, 2021-2028 (IN $ MILLION)
FIGURE 79: GLOBAL BIOMATERIALS MARKET, BY PLASTIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 80: GLOBAL PLASTIC SURGERY MARKET, BY SOFT-TISSUE FILLERS, 2021-2028 (IN $ MILLION)
FIGURE 81: GLOBAL PLASTIC SURGERY MARKET, BY CRANIOFACIAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 82: GLOBAL BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 83: GLOBAL NEUROLOGICAL/CENTRAL NERVOUS SYSTEM MARKET, BY SHUNTING SYSTEMS, 2021-2028 (IN $ MILLION)
FIGURE 84: GLOBAL NEUROLOGICAL/CENTRAL NERVOUS SYSTEM MARKET, BY CORTICAL NEURAL PROSTHETICS (CNP), 2021-2028 (IN $ MILLION)
FIGURE 85: GLOBAL NEUROLOGICAL/CENTRAL NERVOUS SYSTEM MARKET, BY HYDROGEL SCAFFOLDS, 2021-2028 (IN $ MILLION)
FIGURE 86: GLOBAL NEUROLOGICAL/CENTRAL NERVOUS SYSTEM MARKET, BY NEURAL STEM CELL ENCAPSULATION, 2021-2028 (IN $ MILLION)
FIGURE 87: GLOBAL BIOMATERIALS MARKET, BY TISSUE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 88: GLOBAL TISSUE ENGINEERING MARKET, BY SCAFFOLDS FOR REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 89: GLOBAL TISSUE ENGINEERING MARKET, BY NANOMATERIAL FOR BIOSENSING, 2021-2028 (IN $ MILLION)
FIGURE 90: GLOBAL TISSUE ENGINEERING MARKET, BY TAILORING OF INORGANIC NANOPARTICLES, 2021-2028 (IN $ MILLION)
FIGURE 91: GLOBAL BIOMATERIALS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 92: GLOBAL OTHER APPLICATIONS MARKET, BY DRUG DELIVERY SYSTEMS, 2021-2028 (IN $ MILLION)
FIGURE 93: GLOBAL OTHER APPLICATIONS MARKET, BY GASTROINTESTINAL APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 94: GLOBAL OTHER APPLICATIONS MARKET, BY BARIATRIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 95: GLOBAL OTHER APPLICATIONS MARKET, BY URINARY APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 96: NORTH AMERICA BIOMATERIALS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 97: UNITED STATES BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 98: CANADA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 99: EUROPE BIOMATERIALS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 100: GERMANY BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 101: FRANCE BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 102: UNITED KINGDOM BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 103: ITALY BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 104: RUSSIA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 105: POLAND BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 106: BELGIUM BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 107: REST OF EUROPE BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 108: ASIA-PACIFIC BIOMATERIALS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 109: CHINA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 110: JAPAN BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 111: INDIA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 112: AUSTRALIA & NEW ZEALAND BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 113: SOUTH KOREA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 114: THAILAND BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 115: INDONESIA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 116: VIETNAM BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 117: REST OF ASIA-PACIFIC BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 118: REST OF WORLD BIOMATERIALS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 119: LATIN AMERICA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 120: MIDDLE EAST & AFRICA BIOMATERIALS MARKET, 2021-2028 (IN $ MILLION)


お問合せフォーム

    ※レポートのタイトルは自動で入ります。

    お名前(必須)

    会社名(必須)

    部署名

    メールアドレス(必須)

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ区分(必須)

    お問合せ内容(必須)

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com